te Drug maker Cipla invests Rs 42 crore in digital tech company GoApptiv | Zee Business

Drug maker Cipla invests Rs 42 crore in digital tech company GoApptiv

With the fresh investment, Cipla's total stake in GoApptiv will increase to 22.99 per cent on a fully diluted basis.

Drug maker Cipla invests Rs 42 crore in digital tech company GoApptiv
The company's total stake in GoApptiv will increase to 22.99 per cent on a fully diluted basis, Cipla said in a statement. Logo: Official Website

Drug maker Cipla on Friday said it will invest an additional Rs 42 crore in digital tech company GoApptiv Pvt Ltd. With this, the company's total stake in GoApptiv will increase to 22.99 per cent on a fully diluted basis, Cipla said in a statement.

This is the drug firm's third investment in GoApptiv, which will be made in a combination of equity shares and compulsorily convertible preference shares, it added.

"Our long-standing partnership with GoApptiv has helped us increase penetration in underserved rural areas of India and address critical healthcare gaps where pharmaceutical coverage is limited," Cipla MD and Global CEO Umang Vohra said.

In this era of technology-driven healthcare, the investment will help the company deliver patient-centric solutions and further strengthen digitisation agenda to drive next phase of growth, he added.

Written By: PTI
Updated: Fri, Dec 15, 2023
01:12 pm
PTI
RELATED NEWS
Cipla posts better-than-estimated Q3 results; stock hits all-time high Cipla posts better-than-estimated Q3 results; stock hits all-time high
Cipla Q3 results: 32% rise in net profit to Rs 1,056 crore Cipla Q3 results: 32% rise in net profit to Rs 1,056 crore
Seal integrity issue forces Cipla unit to recall one lot of medication in US Seal integrity issue forces Cipla unit to recall one lot of medication in US

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x